Press 03.22.2023 Cognito beams up $73M for study of light-and-sound neuromod therapy to treat Alzheimer’s Fierce Biotech Share Article
Cognito Shares HOPE Study Results at CTAD Business Wire 11.16.2026 Read More: Cognito Shares HOPE Study Results at CTAD
Cognito Expands Executive Leadership Team Business Wire 11.12.2026 Read More: Cognito Expands Executive Leadership Team
Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer’s Disease PR Newswire 10.13.2026 Read More: Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer’s Disease